. 2015 Jun 26;4(3):R25–R36. doi: 10.1530/EC-15-0018
This work is licensed under a Table 1.
Values for cardiac natriuretic peptide plasma levels in heart failure and coronary heart disease.
| Clinical syndrome | Natriuretic peptide (pg/ml) | Value | Reference |
|---|---|---|---|
| Acute heart failure (exclusion cut-off point) | BNP | <100 | (11, 133) |
| NT-proBNP | <300 | ||
| Non-acute presentation of possible heart failure (exclusion cut-off point) | BNP | <35 | (11) |
| NT-proBNP | <125 | ||
| Chronic heart failure (indicators of high risk) | BNP | >125 | (134) |
| NT-proBNP | >1000 | ||
| Unstable angina (indicators for non-invasive stress testing) | BNP | <80 | (135) |
| NT-proBNP | <250 | ||
| Stable chronic coronary disease (cardiovascular death %) | BNP | Q I <18 (8) | (51) |
| Q II 18–42 (10) | |||
| Q III 43–102 (15) | |||
| Q IV >102 (28) | |||
| NT-proBNP | Q I <74 (4) | ||
| Q II 74–174 (9) | |||
| QIII 175–460 (17) | |||
| Q IV >460 (30) |
Q, quartile.